## 

|Legal and Administrative<br>Details|Legal and Administrative<br>Details|Legal and Administrative<br>Details||
|---|---|---|---|
|Chairman's|Annual Report||4-5|
|Trustees' Report, including||the Strategic report|6-I9|
|Independent|Auditor's<br>Report||20-23|
|Consolidated|Statement of|Financial Activities||
|Comparative|Consolidated|Statement ofFinancial Activities|25|
|Consolidated|Balance Sheet||26|
|Charity Balance Sheet|||27|
|Consolidated|Statement of|Cash Flows|28|
|Principal<br>accounting<br>policies|||29-32|
|Notes to the|financial<br>statements||33-52|



## 



## 



## 

## 

## 

## 



## 



## 



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

|||||Notes|Unrestricted|Restricted|Total ZOZ3|'I i&{,:.I 2022|
|---|---|---|---|---|---|---|---|---|
||||||Funds|Funds|||
|Income|||||||||
|Income resources from generated|||funds||||||
|Voluntary<br>income|||||5,8I9,I46|I07,683|5,926,829|5,590, I90|
|Grant funding||||||||I,{i0', I87|
|Income from generated|funds||||||||
|Income from Integrated||Care Board|||I,988,8I6|584,5I7|2,573,333|I,3{l{t{iZO|
|Activities for raising funds|||||I,209,776||I,209,776|I, I83,{i30|
|Investment<br>income|||||2I8,865||2I8,865|225 Bi) I|
|Other incoming<br>resources|||||265,707||265,707|ZZ-l,{i34|
|Total income|||||9,5023IO|692300|IO,I94,5IO|IO,I35,I52|
|Expenditure|||||||||
|Cost ofgenerating<br>funds|||||(3,439,589)||(3,439,589),;Z,5 I{i,738)||
|Charitable<br>activities|||||(5,60I,277)|(302,660)|(5,903,937),5,8o-l,7||
|Total expenditure|||||(9,040,866)|(302,660)|(9343,526)|(8,37I,530)|
|(Loss)/Gain<br>on investments||||I3|(754,593)||(754,593)|I ill, {i')0|
|Net income /(expenditure)|||||(293,I49)|389,540|9639I|I,9I2,3IZ|
|Transfers|||||54|(54)|||
|Net movements<br>in funds|||||(293,095)|389,486|96,39I|I,9I2,3I2|
|Fund balances brought||forward|as at I April||||||
|2022|||||I5,867,I77|909,029|I6,776,206|I4,8{i3.)')-I|
|Fund balances carried|forward||at3I March||||||
|2023||||2I/23|I5,574,082|Ir298,5I5|I6,872,597|I6,776,206|





## 

|||||Urlreslxlcted||Total|
|---|---|---|---|---|---|---|
|||||Funds|Funds|2022|
|Income|||||||
|Donations<br>and voluntary||income|||||
|Voluntary<br>income||||5,I90,037|400,I53|5,590,I90|
|Grant funding|||||I,604,I87|I,604,I87|
|Income from generated|funds||||||
|Income from Integrated||Care Board||I,306,620||I,306,620|
|Activities for raising|funds|||I,I83,630||I,I83,630|
|Investment<br>income||||255,89I||255,89I|
|Other income||||224,634||224,634|
|Total income||||8,I30,8IZ|2,004,340|IO,I35,ISZ|
|Expenditure|||||||
|Cost ofraising funds||||(2,5I6,738)||(2,5I6,738)|
|Charitable<br>activities||||(4,I I0,628)|(I,744,I64)|(5,854,792)|
|Impairment<br>ofinvestment|||||||
|Total expenditure||||(6,627,366)|(I,744,I64)|(8,37I,530)|
|(Loss) / Gain on investment|||assets|I48,690||I48,690|
|Net income / (expenditure)||||I,652,I36|260,I76|I,9IZPI2|
|Transfers|||||||
|Net movements<br>in funds||||I,653,879|258,433|I,9IZQIZ|
|Fund balances brought|forward at IApril||||||
|202I||||I4,2I3,298|650,596|I4,863,894|
|Fund balances carried|forward at3IMarch 2022|||I5,867,I77|909,029|I6,776306|





## 

|||||Company|Company|number 1231909|||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||Notes|2023|2023|2()22||r()22|
|Fixed assets|||||||||||
|Intangible<br>assets|||||II||I6,470|||25,8.r!|
|Tangible<br>assets|||||I2||5,78I,5I6||4,-I36,4 I !||
|Investments|||||I3||7,0I4,668||8,5 I5,677||
||||||||I2,8I2,654|I|7|)77 t)39|
|Current assets|||||||||||
|Stocks|||||I4|46,954||33,864|||
|Debtors|||||I5|2,365,336||3,2 I5,355|||
|Cash and cash equivalents|||||I6|2,60I,663||2,37i, IO')|||
|||||||S,0I3,953||5,620,328|||
|Creditors: amounts||falling due within||one|||||||
|year|||||I7|(847,0I0)||1,7 I5,06I;i|||
|Net current assets|||||||4,I66,943||3|t)05 267|
|Provisions<br>for liabilities|||||I8||(I07,000)||'|I07,00()',|
|Net assets|||||||I6,872,597|I|6,/ /6, 2()(s||
|Income Funds|||||||||||
|Restricted<br>funds|||||2I||I,298,5I5|||')0',02')|
|Unrestricted<br>funds|||||||||||
|Designated<br>funds|||||22||I,050,000||3,4') ',52 I||
|Other charitable|funds||||23||I3,897,489||()"')I 4 ()||
|Revaluation<br>reserve|||||23||626,593||I,38I, I86||
|Total funds|||||||I6,872,597|!6,/76,2()6|||
|inancial st tements|||were approved|and|authorised|for issue by the Board ofTrustees||on 26 July 2023.|||





## 

## 

|||||Notes|2023|2023|2022|2022|
|---|---|---|---|---|---|---|---|---|
|Fixed assets|||||||||
|Intangible<br>assets||||II||I6,470||25,85 I|
|Tangible<br>assets||||I2||5,78I,SI6||4,-I30,4 I I|
|Investment<br>in subsidiary|||undertaking|I3||2|||
|Investments||||I3||7,0I4,668||8 &In 677|
|||||||IZ,8I2,656||I2,977,9-) I|
|Current assets|||||||||
|Debtors||||I5|2,537,563||3,060,t)72||
|Cash and cash equivalents||||I6|2,I70,472||l,779,743||
||||||4,708,035||5,290,743||
|Creditors: amounts||falling due within one|||||||
|year||||I7|(724,276)||||
|Net current assets||||||3,983,759||3,8(r2,')30|
|Provisions<br>for liabilities||||I8||(I07,000)||,'107,000 '|
|||||||I6,689,4I5||I6,733,87 I|
|Income Funds|||||||||
|Restricted<br>funds||||ZI||I,298,5I4||')0'),02')|
|Unrestricted<br>funds:|||||||||
|Designated<br>funds<br>Other charitable<br>funds<br>Revaluation<br>reserve||||22<br>23<br>23||I,050,000<br>I3,7I4,308<br>626,593||3,494,52 I<br>I0,')4 ), I35<br>!,38I,I 8(a|
|Total funds||||||I6,689,4I5||I6,733,87 I|





## 

||||2023f|2023|2022|2022|
|---|---|---|---|---|---|---|
|Cash Rows from operating<br>activities|||||||
|Net income /(outgoing)<br>resources|||96,39I||I,'1 12,312||
|Adjustments<br>for:<br>Investment<br>income||3|(2I 8,865)||;ZZSs,iq)9!'||
|Amortisation||II|I0,378||10,04(s||
|Depreciation||I2|2I2,6I5||28'l,95(i||
|Profit on disposal ofinvestments||13|(I28,726)||'4,317')||
|Decrease/<br>increase in stocks<br>(Decrease) / increase in trade and||I4<br>IS|(I3,090)<br>850,0I9||1,(i(i7<br>'1,201,(i90')||
|other receivables|||||||
|(Decrease)/increase<br>in trade and other||I7|(868,050)||1,14c1,094||
|payables|||||||
|Increase in provisions||I8|||107,000||
|Revaluation ofinvestments||I3|754,593||(148,(i90)||
|Cash flows generated<br>from operating||||695,265||I,888,487|
|activities|||||||
|Cash flows from investing<br>activities|||||||
|Purchase ofproperty<br>plant and equipment<br>Purchase ofintangible<br>fixed assets||I2<br>II|(I,557,720)<br>(997)||'2 1429~3 '<br>),'3,210;)||
|Purchase ofinvestments||I3|(I33,289)||; I 7cs,(sS(s,l||
|Proceeds from sale ofinvestments||I3|I,008,430||(s,8(s(i||
|Investment<br>income||3|2I8,865||225,891||
|Cash flows generated<br>from investing|activities|||(464,7II)||(2,092,062)|
|Net (decrease) / increase in cash and cash||||230,554||(203,575)|
|equivalents|||||||
|Cash and cash equivalents<br>at I April||||2,37I,I09||2,574,684|
|Cash and cash equivalents<br>at 3I March||I6||2,60I,663||2,37I,I09|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

|||||||Total|1o.al|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|2023|2022|
|Donations|(including||gift aid)|1,493,79I|I07,683|I,60I,474|I 736')8(i|
|Gifts in kind||||38,633||38,633|31,I 6')|
|Legacies||||I,499,420||I,499,420|I 4-I3,473|
|Memorials||||25I,007||25I,007|255,260|
|Donated goods||||2,5I4,900||2,5I4,900|2 0')5 35')|
|Christmas|Appeal|||ZI,395||2I,395|27,9!3|
|Grant funding|||||||l,(i()4,187|
|||||5,8I9,I46|I07,683|5,926,829|7, 1t)4,377|
|Activities|for|raising|funds|||||
|||||||2023|2022|
|Unrestricted||funds||||||
|Lottery income||||||446,268|-!68,676|
|Events and|promotions||income|||585,067|5(i5,203|
|Profit from|Willen Hospice Ventures|||shops||I78,441|14'),751|
|||||||I,209,776|1,183,630|



|||Z023|2022|
|---|---|---|---|
|Unrestricted|funds|||
|Listed investments||2I8,523|225.082|
|Bank deposits||342|SO')|
|||2I8,865|225,8') I|





## 

## 

## 

|||||2023|2022|
|---|---|---|---|---|---|
|Unrestricted|funds|||||
|Education||||39,570|-II,583|
|Catering||||32,4I8|29,032|
|Job Retention|Scheme||||823|
|Retail business|support||grant||I00,275|
|Other miscellaneous||income||36,752|I I,830|
|Profit on sale|ofinvestments|||I28,726|4,3I7|
|Shop Rent||||28,24I|37,774|
|||||265,707|224,634|



|2479448) is s|et out below:||||
|---|---|---|---|---|
||||2023|2022|
|Turnover|||I,209,776|2,7I7,388|
|Cost ofsales|||(327,858)|(2G3,948)|
|Administrative<br>expenses|||88I,9I8|2,453,440|
|Other operating|income||(488,G22)|(2,II5,469)|
|Operating<br>profit|||393,296|439,069|
|Interest receivable|and similar income||207|IOZ|
|Profit for the year and total comprehensive||income|393,503|439,I7I|





## 

## 

|The net|assets an|d liabilities ofth|e subsidiary<br>were:|||
|---|---|---|---|---|---|
|||||2023|70))|
|Current<br>assets||||5I6,435|660,70')|
|Creditors:|amounts|falling due within|one year|(333,250)|;(iI8,36') 'i|
|Total net|assets|||I83,I85|42,340|
|Aggregate|share capital and reserves|||I83,I85|42,340|



## 

||||Direct costs|Support costs|Total|J o1aJ|
|---|---|---|---|---|---|---|
|||||(Note bdow)|2023|7(FZ 7|
|Costofraising funds|||||||
|Trading|||2,060,925|3I,462|2,092,387|J,343,4')2|
|Lottery|||I34,968|99.758|234,726|256,772|
|Events and|fundraising||I55,265|I II,I35|266,400|GOI ')73|
|Voluntary|fundraising|costs|785,I8I|60,895|846,076|314,50 I|
||||3,136,339|303,250|3,439,589|),5 I6,738|
|Charitable|activities||||||
|In house|||3,479,364|325,00I|3,804,365|3Q) 0 i)|
|Willen At|Home||I,209,I82|64,902|I,274,084|I,254,55(i|
|Wellbeing|(I(Therapeutic||54I,372|5,8I6|547,I88|810 07')|
|Lymphoedema<br>Service|||I95,377|8,949|204,326|268,68(~|
|Governance|||27,500|46,474|73,974|I 77,3')2|
||||5,452,795|45I,I42|5,903,937|5,85-.',7')2|
|Total expenditure|||8,589,I34|754,392|9,343,526|8,37I,530|





## 

## 

## 

## 

## 

||||The group|The Hospice||
|---|---|---|---|---|---|
|||2023|2022||2022|
|Auditor remuneration||||||
|Audit services||25,000|I5, I<br>I0|25,000||
|Non-audit<br>services||5,IOO|2,450|5,IOO||
|Amortisation||I0,378|I0,046|I0,378|I0,04(i|
|Depreciation||2I2,6I5|28'),') 5(s|2I2,6I5|28'),056|
|Other operating|lease rentals|362,538|342,(a2 I|362,538|342.62 I|



## 

## 

|||2023|2022|
|---|---|---|---|
|Salaries and wages||5,300,350|4,?40,4i3|
|Social security costs||483,836|4 I3,548|
|Pension costs||4I7,538|'3')» 34|
|||6,20I,724|5,5-)II,') l(~|
|Contract staff||294,235|37'),487|
|Health Examination|fees|S,II8||
|||6,50I,077|5 ') )-' ')') ~|





## 

## 

## 

## 

## 



## 

|The group and the Hopsice|||
|---|---|---|
||ITsoftware|Total|
|Cost|||
|At I April 2022|I18,9I5|II8,9I5|
|Additions|997||
|At 3I March 2023|II9,912|II9,9I2|
|Amortisation|||
|At I April 2022|93,064|93,064|
|Amortisation<br>in the year|I0,378|I0,378|
|At3IMarch ZOZ3|I03,442|I03,442|
|Net book amount at3I March 2023|I6,470|I6,470|
|Net book amount at3IMarch 2022|25,85I|25,85I|





## 

## 

## 

|The group and the Hospice|The group and the Hospice|||||
|---|---|---|---|---|---|
||||Asset under|||
|||Freehold|course of||Fundraising|
|||property|construction|Equipment|assets|
|Cost||||||
|At I April 2022||3,053,004|2,395,6I5|684,7II|383,0II|
|Additions||I,309,845|58,057|I63,366||
|Transfers||2,346,425|(2,382,579)|36,I54||
|At3I March|2023|6,709,274|7I,093|884,23I|383,0II|
|Depreciation||||||
|At I April 2022||I,249,607||558,990|325,278|
|Depreciation|in the year|III,527||46,364|9,346|
|Disposals||||||
|At3IMarch|2023|I,36I,I34||605,354|334,624|
|Net book amount at3I||||||
|March 2023||5,348,I40|7I,093|278,877|48,387|
|Net book amount at3I||||||
|March 2022||I,803,397|2,395,6I5|I25,72I|57,733|





## 

## 

|||IT|Motor|Leasehold||
|---|---|---|---|---|---|
|||Hardware|vehides|unprovements||
|Cost||||||
|At I April 2022||292,085|42,774|I60,499|7,0II,699|
|Additions||26,452|||I,557,720|
|Transfers||||||
|At3IMarch|2023|3I8,537|42,774|I60,499|8,569,4I9|
|Depreciation||||||
|At I April 2022||243,I23|37,79I|I60,499|2,575,288|
|Depreciation|in the year|44,078|I,300||2I2,6I5|
|Transfers||||||
|At 3I March|2023|287,20I|39,09I|I60,499|2,787,903|
|Net book amount at3I||||||
|March ZOZ3||3I,336|3,683||5,78I,SI6|
|Net book amount at3I||||||
|March 2022||48,962|4,983||4,436,4II|





## 

## 

## 

||||Historical||Market|
|---|---|---|---|---|---|
||||cost|Revaluation|value|
|Valuation||||||
|At I April|2022||7,I34,49I|I,38I,I86|8,5I5,677|
|Purchases|and additions|from|I33,289||I332.89|
|reinvestment||||||
|Disposals|||(879,705)|(I28,726)|(I,008,43I)|
|Unrealised|(loss) on revaluation|||(625,867)|(625,867)|
|At3I March 2023|||6,388,075|626,593|7,0I4,668|



## 




## 

## 

## 

|rs||||||
|---|---|---|---|---|---|
||||||The Hospice|
|||2023|7077|2023|7()7 7|
|Trade debtors||I,568,467|344,')2()|I,56I,974|336,795|
|Other debtors||74,I42|I47,7 I ')|73,663|I47,360|
|Prepayments|and accrued income|722,727|2,722,7 I6|69I,408|2,6')5,723|
|Amounts<br>owed by subsidiary||||||
|undertaking||||2I0,5I8|381,094|
|||2,365,336|3,2 I5,355|2,537,563|3,560 ')68|



|||||||The group|||The Hospice|
|---|---|---|---|---|---|---|---|---|---|
||||||2023||7()7 7|2023|7022|
|Cash at bank and||in|hand||2,60I,649|2,37I,O')0||2,I70,458|l,77'),724|
|Cash held by investment||||manager|I4|||I4||
||||||2,6IOI,663|7,27I,I09||2,I70,472|l,779,743|
|itors: amounts||falling||due within|one year|||||
|||||||The group||The Hospice||
||||||2023||7077|2023|7()77|
|Trade creditors|||||I6I,435|8|I3,7')6|I53,I64|738,266|
|Social security|and|other taxes|||II8,I64||')5,'138|II8,I63|')s ')38|
|Pension contributions|||||59,693||6(),74!2|59,693|60,742|
|Other creditors|||||3,590||8,344|3,590|8,544|
|Accruals and deferred|||income||504,I28|736,04 I||389,666|574,2') 5|
||||||847,0I0|l,7I5,06I||724,276|l,477,785|





## 

|18 Provisions<br>For liabilities|18 Provisions<br>For liabilities|18 Provisions<br>For liabilities|||||||
|---|---|---|---|---|---|---|---|---|
|||||||The group|The|Hospice|
||||||2023|?0??|2023|2022|
|Dilapidation<br>provisions|||||I07,000|107,0(X)|I07,000|107,000|
||||||707000|107,000|I07,000|107,000|
|l9 Financial<br>instruments|||||||||
||||||||The|Hospice|
||||||2023|?0??|2023|?()??|
|Financial|assets:||||||||
|Financial|assets measured||at|fair value|||||
|through|profit and|loss|||2,60I,663|?,d? 1,071|2,I70,472|I,')65,705|
|Financial|assets measured||at|amortised|||||
|cost|||||2,I72,35I|?')')5 0')8|2,380,804|3,117,425|
||||||4,774,0I4|5,416, 160)|4,55I,276|4,c)47,130|
|Financial|liabilities:||||||||
|Financial|liabilities|measured||at|||||
|amortised|cost||||725,7I5|1,4')0,042|7I2,944|I,487,(721|





## 

|||Unrestricted|Restricted||
|---|---|---|---|---|
|||funds|funds|Total funds<br>f|
|Intangible<br>fixed assets||I6,470||I6,470|
|Tangible fixed assets||5,78I,SI6||5,781,5I6|
|Investments||7,0I4,668||7,0I4,668|
|Current<br>assets||3,7I5,439|I,298,5I4|5,0I3,953|
|Current<br>liabilities||(847,0I0)||(847,0IO)|
|Provisions||I07,000||I07,000|
|||I5,574,083|I,298,5I4|I6,872,597|
|Group —comparative|year||||
|||Unrestricted|Restricted||
|||funds|funds|Total funds|
|Intangible<br>fixed assets||25,85I||25,85I|
|Tangible<br>fixed assets||4,436,4II||4,436,4II|
|Investments||8,5I5,677||8,5I5,677|
|Current<br>assets||4,7II,299|909,029|5,620,328|
|Current<br>liabilities||(I,jl 5,06I)||(I,7I5,06I)|
|Provisions||I07,000||I07,000|
|||I5,867,I77|909,029|I6,776,206|





## 

## 

## 

||||||At|
|---|---|---|---|---|---|
||At I April||||3IMarch|
||2022|Income|Expenditure<br>f|Transfers|2023|
|Education|68,282|30,000|(33,790)||64,492|
|Clinical equipment|5,708|26,074|(22,453)|(287)|9,042|
|Willen at Home|257|584,5I7|(ZI,OOO)||563,774|
|Capital Appeal|686,705|27,547|(88,669)||625,583|
|Wellbeing<br>and Therapeutic|37,528|I8,476|(42,399)|233|I3,838|
|Miscellaneous|29.728|355|(20,040)||I0,043|
|CCG COVID-19 Funding|30,82I||(19,078)||II,743|
|Cancer Care in the||||||
|Community|50,000|5,23I|(55,23I)|||
||909,029|692300|(302,660)|(54)|IP98,5IS|



## 



## 

## 

## 

||||||At|
|---|---|---|---|---|---|
||At I April||||3IMarch|
||202I|Income|Expenditure|Transfers|2022|
|Education|2,282|66,000|||68,282|
|Clinical equipment|6,764|543|(1,493)|(I06)|5,708|
|Willen at Home|257|2,I62|(2,I63)||257|
|Capital Appeal|309,845|462,I27|(85,267)||686,705|
|Wellbeing<br>and Therapeutic|23,2I8|57,I38|(42,823)|(5)|37,528|
|Miscellaneous|29,588|II,423|(9,650)|(I,633)|29,728|
|CCG COVID-I9 Funding|278,642||(247,82I)||30,82I|
|Hospice UK Funding||I,II6,187|(I,II6,I87)|||
|Cancer Care in the||||||
|Community||I64,635|(II4,635)||50,000|
|Winter Pressures||II2,000|(II2,000)|||
|Bereavement<br>Project||IZ,I25|(I2,125)|||
|Total|650,596|Z,004,340|(I,744,I64)|(I,743)|909,029|





## 

## 

## 

|The group and the Hospice —current|The group and the Hospice —current|The group and the Hospice —current|year|||||
|---|---|---|---|---|---|---|---|
|||||At I April||Transfers|At 3IMarch|
|||||2022|Expenditure|(see below)|2023|
|||||||E||
|Property||||I,803,403|(59,378)|(I,744,025)||
|Hospice|development|||I,289,768|(I,I82,538)|892,770|I,000,000|
|Other fixed assets||||337,82I|(93,605)|(244,2I6)||
|Retail outlet refurbishment||||5,000||(5,000)||
|IT replacement||||25,000|||25,000|
|Clinical|equipment|||529||(529)||
|Planned|preventative|maintenance||33,000||(8,000)|25,000|
|Total||||3,494,52I|(I,335,52I)|(I,I09,000)|I,050,000|





## 

## 

## 

|||||At IApril||Transfers|At 3I March|
|---|---|---|---|---|---|---|---|
|||||202I|Expenditure|(see below)|2022|
|Property||||I,863,079|(59,676)||I,803,403|
|Hospice|development|||3,378,232|(2,088,464)||I,289,768|
|Other fixed assets||||444,009|(I06,I88)||337,82I|
|Retail outlet refurbishment||||5,000|||5,000|
|ITreplacement||||25,000|||25,000|
|Clinical|equipment|||36,000|||36,000|
|Planned|preventative||maintenance|33,000|||33,000|
|Total||||5,784,320|(2,289,799)||3,494,52I|
|23 Unrestricted||funds||||||



||Designated|Other|||
|---|---|---|---|---|
||funds (see|charitable|Revaluation||
||note ZI)|funds|reserve|Total|
|At I April 2022|3,494,52I|I0,99I,470|I,38I,I86|I5,867,I77|
|Income||9,502,3IO||9,502,3I0|
|Expenditure|(I,335,52I)|(7,705,345)||(9,040,866)|
|(Loss)/ (gain) on revaluation|||(625,867)|(625,867)|
|Disposals|||(I28,726)|(I28,726)|
|Transfers (see note I3RZI)|I,I09,000|I,I09,054||54|
|At3IMarch 2023|I,050,000|I3,897,489|626,593|I5,574,082|





## 

## 

## 

## 

||Designated|Other|||
|---|---|---|---|---|
||funds (see|charitable|Revaluation||
||note 22)|funds|reserve|Total|
|At I April 202I|5,784,320|7,I96,482|I,232,496|I4,2I3,298|
|Income||8,I30,8I2||8,I30,8I2|
|Expenditure|(2,289,799)|(4,337,567)||(6,627,306)|
|(Loss)/ gain on revaluation|||I53,007|I53,007|
|Disposals|||(4,3I7)|(4,3I7)|
|Transfers (see note 22)||I,743||I,743|
|At3IMarch 2022|3,494,52I|I0,99I,470|I,38I,I86|I5,867,I77|



||Designated|Other|||
|---|---|---|---|---|
||funds (see note|charitable|Revaluation||
||22)|funds|reserve|Total|
|At I April 2022|3,494,52I|I0,949,I35|I,38I,I86|I5,824,842|
|Income||8,909,869||8,909,869|
|Expenditure|(I,335,52I)|(7,253,750)||(8,589,27I)|
|(Loss) / gain on revaluation|||(625,867)|(625,867)|
|Disp osals|||(I28,726)|(I28,726)|
|Transfers<br>(see note ZZ)|I,I09,000|I,I09,054||54|
|At 3I March 2023|I,050,000|I3,7I4,308|626,593|I5,390,90I|





## 

## 


## 

## 



## 

## 

## 



## 

## 

## 

||2023|2022|2023|2022|
|---|---|---|---|---|
||Land and|I;Iiidl iiiid|||
||buildings<br>f|bail dnigs|Other<br>f|O(lici|
|In one year or less|279,60I|I 4I I),2')tl|I I8,746|!4,0(i I|
|Between two and five|502,304|367,')8(i|||
|years|||||
|Over five years|250,IIO|I2I,250|||
||I,032,0I5|I,907,534|II8,746|I4,0(i I|



## 

## 

## 

## 

